Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2020 Oct;42(7):e637–e640. doi: 10.1097/MPH.0000000000001604

Fig 1:

Fig 1:

Average Total Neuropathy Score-5 for healthy and obese ALL patients during the first 12 months of treatment with vincristine. Data are presented as average score ± SD. *p= 0.03.